Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology · Autoimmune Encephalitis

Why Rule Out Infection Before Autoimmune Encephalitis?

At a Glance

Before treating suspected seronegative autoimmune encephalitis, doctors look for infections because viruses, bacteria, and fungi can mimic it, while high-dose steroids may worsen an untreated infection. Spinal-fluid tests and the full clinical picture help determine when immune treatment is safe.

When a patient has symptoms of encephalitis, doctors must urgently assess for infections before starting treatments like high-dose steroids because serious brain infections (such as viruses, bacteria, or fungi) can cause similar symptoms and test findings [1]. If a patient has an active infection and is given strong immune-suppressing drugs, the immune system may struggle to fight off the germ [2]. Therefore, doctors must carefully evaluate the risk of infection while deciding when to use therapies that calm the immune system.

The Different Types of Immune Treatments

Not all immune treatments carry the same risk:

  • Immunosuppressants (like high-dose corticosteroids or rituximab) strongly suppress the immune system. An intact immune response is needed to control neurotropic pathogens (germs that infect the nervous system) [3][2]. If these are given during an unrecognized brain infection, the infection can progress more rapidly [4].
  • Immunomodulators (like IVIG—Intravenous Immunoglobulin) and Plasma Exchange (PLEX, a process that filters antibodies from the blood) work differently and generally carry a different risk profile than strong immunosuppressants [5]. Doctors consider the specific treatment when weighing infection risks.

Lookalike Conditions and Antibody-Negative Encephalitis

In cases of antibody-negative autoimmune encephalitis (where no specific antibody is found in the blood or spinal fluid), the diagnosis is based on the patient’s symptoms, MRI, EEG, spinal-fluid findings, and the reasonable exclusion of alternative causes [6]. Studies show that some patients initially suspected of having autoimmune encephalitis are ultimately found to have a central nervous system infection instead [1]. Viruses like Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV) are common infectious mimics [7]. Infection and autoimmunity can also coexist; for instance, HSV encephalitis can trigger autoimmune encephalitis weeks later [8].

Balancing Urgency with Safety: Empiric Treatment

Suspected encephalitis is time-sensitive. Delaying immune therapy for true autoimmune encephalitis can lead to worse outcomes [9], but suppressing the immune system during an active infection requires careful consideration [10]. To manage this, medical guidelines recommend empiric treatment—starting treatment based on clinical suspicion before test results are finalized [7]. When a patient arrives with severe brain inflammation, doctors typically draw spinal fluid and may immediately start intravenous antivirals (like acyclovir for HSV) [7][11]. Depending on the patient’s age, immune status, and symptoms, doctors might also add antibiotics or other treatments if bacterial or fungal infections are suspected [12].

Testing and Moving Forward

While the medical team treats likely infections empirically, they run tests like cultures (growing the germ in a lab) and PCR (detecting the germ’s DNA) on the spinal fluid [13]. A single negative test does not completely rule out an infection, especially if done very early in the illness [14][15]. The relevant infection tests depend on travel, animal or tick exposure, immune status, medications, and the MRI pattern. Once the clinical picture strongly points to an autoimmune cause and the risk of an untreated infection is considered low, doctors may decide to initiate immune treatment after weighing the risks and the need for urgent therapy [6][16].

Emergency Warning: Suspected encephalitis is a medical emergency. Seek immediate emergency evaluation for new or worsening confusion, seizures, reduced consciousness, severe headache with fever or stiff neck, or rapidly progressive neurologic symptoms. Do not start, stop, or delay prescribed antimicrobials or immunotherapy without consulting your clinical team.

Common questions in this guide

Why is infection screening important before immune therapy for seronegative autoimmune encephalitis?
Brain infections caused by viruses, bacteria, or fungi can look like autoimmune encephalitis, especially when no antibody is found. High-dose steroids and other strong immune-suppressing medicines can weaken the body’s ability to control an infection and allow it to worsen. IVIG and plasma exchange affect the immune system differently, so their risks are weighed individually.
Which infections can look like autoimmune encephalitis?
Herpes simplex virus and varicella-zoster virus are common infectious mimics, although bacterial or fungal infections may also be considered based on a person’s symptoms, immune status, travel, and exposures. Infection and autoimmune inflammation can sometimes occur together, such as autoimmune encephalitis developing weeks after herpes simplex encephalitis.
How do doctors test for a brain infection when autoimmune encephalitis is suspected?
Doctors usually collect spinal fluid with a lumbar puncture and use PCR to detect germ genetic material and cultures to try to grow germs. They also consider the MRI, symptoms, illness timing, travel, tick or animal exposure, immune status, and medications. A negative test early in the illness may not completely rule out infection.
Why might doctors start acyclovir before infection test results are final?
Encephalitis can worsen quickly, and delaying treatment for a serious infection can be dangerous. Clinicians may start intravenous acyclovir when herpes simplex virus is possible and add antibiotics or other antimicrobial treatment when bacterial or fungal infection is a concern, then adjust treatment as results and the clinical picture become clearer.
Does a negative spinal-fluid infection test mean steroids or IVIG can start right away?
Not always. A negative result, especially early in the illness, does not completely exclude infection, so doctors interpret it alongside test timing, symptoms, MRI findings, exposures, and the overall clinical course. Immune treatment may begin when autoimmune encephalitis is more likely and the risk of untreated infection is considered acceptably low.
Are steroids, IVIG, and plasma exchange equally risky if an infection is possible?
No. High-dose corticosteroids and rituximab strongly suppress immune defenses, while IVIG and plasma exchange work differently and generally have different risk profiles. The medical team weighs the suspected infection, treatment urgency, immune status, and risks of delaying treatment.
What symptoms require emergency evaluation for possible encephalitis?
New or worsening confusion, seizures, reduced consciousness, severe headache with fever or stiff neck, or rapidly worsening neurologic symptoms require emergency evaluation. Do not start, stop, or delay antimicrobial or immune treatment without speaking with the clinical team.

Get notified when new evidence is published on Non-specific autoimmune supratentorial encephalitis without characteristic antibodies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Differential diagnosis and comparison of diagnostic algorithms in children and adolescents with autoimmune encephalitis in Spain: a prospective cohort study and retrospective analysis.

    Olivé-Cirera G, Fonseca E, Chen LW, et al.

    The Lancet. Neurology 2025; (24(1)):54-64 doi:10.1016/S1474-4422(24)00443-5.

    PMID: 39706634
  2. 2

    Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).

    Bauer J, Gold R, Adams O, Lassmann H

    Acta neuropathologica 2015; (130(6)):751-64 doi:10.1007/s00401-015-1471-7.

    PMID: 26323992
  3. 3

    JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.

    Harypursat V, Zhou Y, Tang S, Chen Y

    AIDS research and therapy 2020; (17(1)):37 doi:10.1186/s12981-020-00293-0.

    PMID: 32631361
  4. 4

    Encephalomyelomeningitis Caused by Balamuthia mandrillaris: A Case Report and Literature Review.

    Fan X, Chen T, Yang H, et al.

    Infection and drug resistance 2023; (16()):727-733 doi:10.2147/IDR.S400692.

    PMID: 36756612
  5. 5

    Immune-mediated encephalitis for the infectious disease specialist.

    Venkatesan A

    Current opinion in infectious diseases 2019; (32(3)):251-258 doi:10.1097/QCO.0000000000000546.

    PMID: 31021956
  6. 6

    Evaluation of Clinical and Paraclinical Findings for the Differential Diagnosis of Autoimmune and Infectious Encephalitis.

    Wagner JN, Kalev O, Sonnberger M, et al.

    Frontiers in neurology 2018; (9()):434 doi:10.3389/fneur.2018.00434.

    PMID: 29951031
  7. 7

    State of the Art: Acute Encephalitis.

    Bloch KC, Glaser C, Gaston D, Venkatesan A

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2023; (77(5)):e14-e33 doi:10.1093/cid/ciad306.

    PMID: 37485952
  8. 8

    Autoimmune Encephalitis with Autoantibodies to NMDAR1 following Herpes Encephalitis in Children and Adolescents.

    Quade A, Rostasy K, Wickström R, et al.

    Neuropediatrics 2023; (54(1)):14-19 doi:10.1055/s-0042-1757706.

    PMID: 36543183
  9. 9

    Prognosticating autoimmune encephalitis: A systematic review.

    Broadley J, Seneviratne U, Beech P, et al.

    Journal of autoimmunity 2019; (96()):24-34 doi:10.1016/j.jaut.2018.10.014.

    PMID: 30595145
  10. 10

    Autoimmune Encephalitis Misdiagnosis in Adults.

    Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, et al.

    JAMA neurology 2023; (80(1)):30-39 doi:10.1001/jamaneurol.2022.4251.

    PMID: 36441519
  11. 11

    A Prospective Cohort Study to Identify Clinical, Biological, and Imaging Features That Predict the Etiology of Acute Encephalitis.

    Le Maréchal M, Mailles A, Seigneurin A, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (73(2)):264-270 doi:10.1093/cid/ciaa598.

    PMID: 32433723
  12. 12

    Encephalitis and Brain Abscess.

    Venkatesan A

    Continuum (Minneapolis, Minn.) 2021; (27(4)):855-886 doi:10.1212/CON.0000000000001006.

    PMID: 34623096
  13. 13

    Autoimmune and inflammatory neurological disorders in the intensive care unit.

    Legouy C, Cervantes A, Sonneville R, Thakur KT

    Current opinion in critical care 2024; (30(2)):142-150 doi:10.1097/MCC.0000000000001139.

    PMID: 38441114
  14. 14

    Herpes Simplex Virus Encephalitis With Initial Negative Polymerase Chain Reaction in the Cerebrospinal Fluid: Prevalence, Associated Factors, and Clinical Impact.

    de Montmollin E, Dupuis C, Jaquet P, et al.

    Critical care medicine 2022; (50(7)):e643-e648 doi:10.1097/CCM.0000000000005485.

    PMID: 35167501
  15. 15

    Absence of Cerebrospinal Fluid Pleocytosis in Encephalitis.

    Habis R, Kolchinski A, Heck AN, et al.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2025; (81(1)):179-187 doi:10.1093/cid/ciae391.

    PMID: 39096271
  16. 16

    Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR.

    Uy CE, Mayxay M, Harrison R, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2022; (116(10)):959-965 doi:10.1093/trstmh/trac023.

    PMID: 35385878

This page is for informational purposes only and does not constitute medical advice about suspected autoimmune encephalitis or infection treatment. Encephalitis symptoms require urgent evaluation; follow your neurologist and clinical team before starting, stopping, or delaying antimicrobials or immune therapy.